| Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort P Vizcarra, MJ Pérez-Elías, C Quereda, A Moreno, MJ Vivancos, ... The lancet HIV 7 (8), e554-e564, 2020 | 413 | 2020 |
| Linezolid for the treatment of multidrug-resistant tuberculosis J Fortun, P Martín-Dávila, E Navas, MJ Pérez-Elías, J Cobo, M Tato, ... Journal of Antimicrobial Chemotherapy 56 (1), 180-185, 2005 | 333 | 2005 |
| Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio S Serrano-Villar, MJ Pérez-Elías, F Dronda, JL Casado, A Moreno, ... PloS one 9 (1), e85798, 2014 | 258 | 2014 |
| Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy C Gutiérrez, S Serrano-Villar, N Madrid-Elena, MJ Pérez-Elías, ME Martín, ... Aids 30 (9), 1385-1392, 2016 | 221 | 2016 |
| Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy E Navas, P Martín-Dávila, L Moreno, V Pintado, JL Casado, J Fortún, ... Archives of Internal Medicine 162 (1), 97-99, 2002 | 221 | 2002 |
| Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV F Pulido, JR Arribas, R Delgado, E Cabrero, J González-García, ... Aids 22 (2), F1-F9, 2008 | 194 | 2008 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| Influence of liver fibrosis on highly active antiretroviral therapy—associated Hepatotoxicity in Patients with HIV and hepatitis C virus coinfection L Aranzabal, JL Casado, J Moya, C Quereda, S Diz, A Moreno, L Moreno, ... Clinical Infectious Diseases 40 (4), 588-593, 2005 | 182 | 2005 |
| Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis JR Arribas, R Delgado, A Arranz, R Muñoz, J Portilla, J Pasquau, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 147-152, 2009 | 145 | 2009 |
| Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients JL Casado, MJ Perez-Elías, A Antela, R Sabido, P Martí-Belda, F Dronda, ... Aids 12 (11), F131-F135, 1998 | 144 | 1998 |
| High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin A Moreno, C Quereda, L Moreno, MJ Perez-Elías, A Muriel, JL Casado, ... Antiviral therapy 9 (1), 133-138, 2004 | 137 | 2004 |
| Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis I Corral, C Quereda, E Navas, P Martin-Davila, MJ Pérez-Elías, ... European Journal of Clinical Microbiology and Infectious Diseases 23, 471-476, 2004 | 135 | 2004 |
| Long-Term Outcomes among Antiretroviral-Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4+ Cell Counts after Successful … F Dronda, S Moreno, A Moreno, LC José, MJ Pérez-Elías, A Antela Clinical infectious diseases 35 (8), 1005-1009, 2002 | 122 | 2002 |
| Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients L Moreno, C Quereda, A Moreno, MJ Perez-Elías, A Antela, JL Casado, ... Aids 18 (1), 67-73, 2004 | 119 | 2004 |
| Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected C Gutiérrez, L Díaz, A Vallejo, B Hernández-Novoa, M Abad, N Madrid, ... PloS one 6 (12), e27864, 2011 | 117 | 2011 |
| Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir JM Llibre, P Domingo, R Palacios, J Santos, MJ Pérez-Elías, ... Aids 20 (10), 1407-1414, 2006 | 109 | 2006 |
| The development of artificial neural networks to predict virological response to combination HIV therapy B Larder, D Wang, A Revell, J Montaner, R Harrigan, F De Wolf, J Lange, ... Antiviral therapy 12 (1), 15-24, 2007 | 99 | 2007 |
| Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome G Piédrola, JL Casado, E López, A Moreno, MJ Perez‐Elías, ... Clinical endocrinology 45 (1), 97-101, 1996 | 87 | 1996 |
| The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients A Vallejo, C Gutierrez, B Hernandez-Novoa, L Diaz, N Madrid, ... Aids 26 (15), 1885-1894, 2012 | 85 | 2012 |
| Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression F Pulido, I Pérez-Valero, R Delgado, A Arranz, J Pasquau, J Portilla, ... Antiviral therapy 14 (2), 195-201, 2009 | 83 | 2009 |
